Cover Image
市場調查報告書

肺塌陷:全球臨床實驗檢討

Atelectasis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 321700
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
肺塌陷:全球臨床實驗檢討 Atelectasis Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月22日 內容資訊: 英文 53 Pages
簡介

本報告提供肺塌陷的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 肺塌陷
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:呼吸系統疾病臨床實驗上肺塌陷所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:呼吸系統疾病臨床實驗上肺塌陷所佔的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

  • 有代表性的研究機關·醫院臨床實驗概要
    • Dresden University of Technology
    • Hospital Sirio-Libanes
    • The University of Utah
    • Erasmus MC
    • London Health Sciences Centre
    • Herlev Hospital
    • University of Oklahoma
    • University of Medicine and Dentistry New Jersey (Inactive)
    • Massachusetts General Hospital
    • Duke University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2478CTIDB

GlobalData's clinical trial report, "Atelectasis Global Clinical Trials Review, H2, 2014" provides data on the Atelectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atelectasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atelectasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Atelectasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Cdlinical Trials by G7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Atelectasis to Respiratory Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Clinical Trial Overview of Top Institutes / Government
    • Dresden University of Technology
    • Clinical Trial Overview of Dresden University of Technology
    • Hospital Sirio-Libanes
    • Clinical Trial Overview of Hospital Sirio-Libanes
    • The University of Utah
    • Clinical Trial Overview of The University of Utah
    • Erasmus MC
    • Clinical Trial Overview of Erasmus MC
    • London Health Sciences Centre
    • Clinical Trial Overview of London Health Sciences Centre
    • Herlev Hospital
    • Clinical Trial Overview of Herlev Hospital
    • University of Oklahoma
    • Clinical Trial Overview of University of Oklahoma
    • University of Medicine and Dentistry New Jersey (Inactive)
    • Clinical Trial Overview of University of Medicine and Dentistry New Jersey (Inactive)
    • Massachusetts General Hospital
    • Clinical Trial Overview of Massachusetts General Hospital
    • Duke University
    • Clinical Trial Overview of Duke University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Atelectasis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sirio-Libanes, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey (Inactive), 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Atelectasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*

List of Figures

  • Atelectasis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Atelectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Atelectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Atelectasis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Atelectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Atelectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Atelectasis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Atelectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Atelectasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Atelectasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Atelectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Atelectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • GlobalData Methodology
Back to Top